SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-13-006939
Filing Date
2013-04-18
Accepted
2013-04-18 10:23:18
Documents
1
Period of Report
2013-04-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 20338
  Complete submission text file 0001179110-13-006939.txt   22375
Mailing Address C/O SOFINNOVA PARTNERS 17 RUE DE SURENE PARIS XX 75008
Business Address C/O SOFINNOVA PARTNERS 17 RUE DE SURENE PARIS XX 75008 33 1 53 054100
SOFINNOVA CAPITAL VI FCPR (Reporting) CIK: 0001441261 (see all company filings)

State of Incorp.: XX
Type: 4 | Act: 34 | File No.: 001-35869 | Film No.: 13768458

Mailing Address 707 STATE ROAD NEW JERSEY NJ 08540
Business Address 707 STATE ROAD NEW JERSEY NJ 08540 908-741-4323
Omthera Pharmaceuticals, Inc. (Issuer) CIK: 0001477598 (see all company filings)

IRS No.: 263797738 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 17 RUE DE SERENE PARIS I0 75008
Business Address 17 RUE DE SERENE PARIS I0 75008 33 1 53 05 41 13
Sofinnova Partners SAS (Reporting) CIK: 0001574139 (see all company filings)

State of Incorp.: I0 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35869 | Film No.: 13768459